EquitySectoral/ ThematicDirect · Growth
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Aditya Birla Sun Life · Scheme 147409
₹40.76▲ 0.27%NAV · 2026-09-18
Excellent FundScore
AUM
₹1,074 cr
Expense ratio
1.02%
3Y CAGR
22.5%
Risk level
High
Min SIP
₹100
Benchmark
Nifty 500 TRI
Fund manager: Dhaval ShahExit load: Exit load of 1% if redeemed within 30 days.
Excellent · 83/100
A standout fund on our data — strong across almost every dimension.
🎯 For aggressive investors with a 7+ year horizon who can tolerate sharp ups and downs.
📈 Why it could do well
- ✓Compounding well recently — 22.5% CAGR over 3 years.
- ✓Very consistent — delivers dependably across market cycles, ideal for SIPs.
- ✓3Y CAGR: +22.5%
- ✓Positive 3Y windows: 100% of rolling 3Y windows positive
📉 What could drag it down
- •Sectoral/ Thematics are inherently higher-risk — best held 7+ years to ride out swings.
FundScore breakdown
83/100 · Excellent
Returns
Excellent
Consistency
Excellent
Risk-adjusted
Decent
Downside protection
Excellent
Cost efficiency
Strong
Portfolio quality
Average
Each dial rates the fund 0–100 on one factor, computed from real NAV history. Fuller & greener = stronger.
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.